Study: NCT01659086

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational H9N2 vaccine GSK2654911A
Description: 2 or 3 doses of GSK2654911A (different formulations) followed by 1 or 0 dose of saline placebo respectively, depending in the treatment group. All doses to be administered intramuscularly (IM) in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational H9N2 vaccine GSK2654911A
Description: 2 or 3 doses of GSK2654911A (different formulations) followed by 1 or 0 dose of saline placebo respectively, depending in the treatment group. All doses to be administered intramuscularly (IM) in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational H9N2 vaccine GSK2654911A
Description: 2 or 3 doses of GSK2654911A (different formulations) followed by 1 or 0 dose of saline placebo respectively, depending in the treatment group. All doses to be administered intramuscularly (IM) in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational H9N2 vaccine GSK2654911A
Description: 2 or 3 doses of GSK2654911A (different formulations) followed by 1 or 0 dose of saline placebo respectively, depending in the treatment group. All doses to be administered intramuscularly (IM) in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational H9N2 vaccine GSK2654911A
Description: 2 or 3 doses of GSK2654911A (different formulations) followed by 1 or 0 dose of saline placebo respectively, depending in the treatment group. All doses to be administered intramuscularly (IM) in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational H9N2 vaccine GSK2654911A
Description: 2 or 3 doses of GSK2654911A (different formulations) followed by 1 or 0 dose of saline placebo respectively, depending in the treatment group. All doses to be administered intramuscularly (IM) in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational H9N2 vaccine GSK2654911A
Description: 2 or 3 doses of GSK2654911A (different formulations) followed by 1 or 0 dose of saline placebo respectively, depending in the treatment group. All doses to be administered intramuscularly (IM) in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational H9N2 vaccine GSK2654911A
Description: 2 or 3 doses of GSK2654911A (different formulations) followed by 1 or 0 dose of saline placebo respectively, depending in the treatment group. All doses to be administered intramuscularly (IM) in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational H9N2 vaccine GSK2654909A
Description: 2 or 3 doses of GSK2654909A followed by 1 or 0 dose of saline placebo, respectively (treatment 5). All doses to be administered IM in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Investigational H9N2 vaccine GSK2654909A
Description: 2 or 3 doses of GSK2654909A followed by 1 or 0 dose of saline placebo, respectively (treatment 5). All doses to be administered IM in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 1 dose of saline placebo administered intramuscularly (IM) in deltoid region of arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 1 dose of saline placebo administered intramuscularly (IM) in deltoid region of arm.